Abstract:Background and Purpose: Iron plays a crucial role in maintaining cardiac health. However, existing research has focused on understanding how cardiac cells regulates intercellular iron levels through their own cell-autonomous cardiac hepcidin/ferroportin axis. In Addition, several studies have explored the mechanisms linking cardiac dysfunction with iron imbalance. Recent insights also emphasize the importance of Nrf2, a key transcriptional regulator that not only counteracts iron-mediated oxidative stress, but also governs several genes involved in iron metabolism. Consequently, the Nrf2/hepcidin/ferroportin axis is emerging as a central hub connecting cardiac iron metabolism with redox alterations. However, the precise mechanisms linking these components remain elusive. This study aims to elucidate how disruptions in the Nrf2/hepcidin/ferroportin axis contribute to the altered iron metabolism in Myocardial infarction (MI). Experimental Approach: MI was induced in adult Wistar rats by subcutaneous administration of isoproterenol (ISO; 85 mg/kg body weight) for two days. H9c2 cardiomyoblasts were differentiated into cardiomyocytes using all-trans-retinoic acid (ATRA, 2.5μM for 5-days) and subjected to hypoxic stress using CoCl2 (100μM). In vitro pharmacological suppression of Nrf2 was performed using brusatol (50nM). Key Results: Morphological examination revealed maladaptive remodeling, and histopathological analysis demonstrated disoriented myofibrils with intense neutrophil infiltration and necrotic impressions in MI-affected animals. Furthermore, elevated levels of labile redox-active iron and inflammatory markers were observed in serum of ISO induced animals. qPCR & Western blot analysis indicated an increase in HIF-1α and hepcidin levels, and downregulation of FTH levels in MI-induced animals, with no significant changes observed in FPN-1. The transcriptional activity of Nrf2 is enhanced in the MI-heart. Moreover, increased levels of NCOA4, beclin-1, and LC3-II/LC3-I, along with decreased P62, suggest enhanced ferritinophagy in MI-induced hearts. Nrf2 was pharmacologically suppressed in differentiated H9c2 cardiomyocytes to explore its potential role in MI pathophysiology. Remarkably, this inhibition rescued CoCl2-induced hypoxic stress, as evidenced by the decreased ferritinophagy and apoptotic cell death. Conclusion and Implications: Augmented Nrf2-transcriptional activity disrupts iron metabolism through the hepcidin/ferroportin axis, leading to iron sequestration and promoting ferritinophagy within cardiomyocytes, thereby exacerbating MI.

Nrf2 Protects From Intermittent Hypoxia-induced Cardiomyopathy via Metallothionein-dependent and Independent Mechanisms

Nrf2 Expression and Function, but Not MT Expression, is Indispensable for Sulforaphane-Mediated Protection Against Intermittent Hypoxia-Induced Cardiomyopathy in Mice.

Intermittent Hypoxia-Induced Cardiomyopathy and Its Prevention by Nrf2 and Metallothionein.

Metallothionein Is Downstream Of Nrf2 And Partially Mediates Sulforaphane Prevention Of Diabetic Cardiomyopathy

Metallothionein Prevents Intermittent Hypoxia-Induced Cardiac Endoplasmic Reticulum Stress and Cell Death Likely Via Activation of Akt Signaling Pathway in Mice.

Metallothionein As a Compensatory Component Prevents Intermittent Hypoxia-Induced Cardiomyopathy in Mice.

Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity.

RTA 408 Ameliorates Diabetic Cardiomyopathy by Activating Nrf2 to Regulate Mitochondrial Fission and Fusion and Inhibiting NF-κB-mediated Inflammation.

Metallothionein Plays A Prominent Role In The Prevention Nephropathy By Sulforaphane Via Up-Regulation Of Nrf2

Combination of Broccoli Sprout Extract and Zinc Provides Better Protection Against Intermittent Hypoxia-Induced Cardiomyopathy Than Monotherapy in Mice

Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress

Metallothionein Protects Against Doxorubicin-Induced Cardiomyopathy Through Inhibition of Superoxide Generation and Related Nitrosative Impairment

Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins

Hypoxia‐inducible Factor 1α is Critically Involved in Metallothionein Protection Against Diabetic Cardiomyopathy

Nrf2 Deficiency Aggravates Angiotensin II-induced Cardiac Injury by Increasing Hypertrophy and Enhancing IL-6/STAT3-dependent Inflammation.

Exercise Mediated Nrf2 Signaling Protects the Myocardium From Isoproterenol-Induced Pathological Remodeling

Enhanced Keap1-Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling in mice

Activation of HIF-1 by Metallothionein Contributes to Cardiac Protection in the Diabetic Heart.

Modulation Of Cytochrome C Oxidase-Va Is Possibly Involved In Metallothionein Protection From Doxorubicin Cardiotoxicity

Ironing out the role of Nrf2 in cardiac iron metabolism during myocardial infarction

Sulforaphane Enhances Nrf2-mediated Antioxidant Responses of Skeletal Muscle Induced by Exhaustive Exercise in HIIT Mice